share_log

Medical Properties Trust Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.9%)

Medical Properties Trust Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.9%)

Medical Properties Trust | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(14.9%)
美股SEC公告 ·  11/08 14:28

Moomoo AI 已提取核心信息

On September 30, 2024, BlackRock, Inc. filed an amended Schedule 13G/A with the SEC, indicating a significant ownership stake in Medical Properties Trust Inc. The filing revealed that BlackRock now beneficially owns 89,509,007 shares of Medical Properties Trust, representing 14.9% of the company's common stock. This position reflects BlackRock's sole voting power over 86,853,098 shares and sole dispositive power over the entire 89,509,007 shares. The filing was made in accordance with Rule 13d-1(b) under the Securities Exchange Act of 1934, which applies to parent holding companies or control persons. The address of BlackRock's principal business office is listed as 50 Hudson Yards, New York, NY 10001. Medical Properties Trust Inc., headquartered in Birmingham, AL, is the issuer of the common stock in question. The filing also notes that the iShares Core S&P Small-Cap ETF, managed by BlackRock, holds more than five percent of Medical Properties Trust's outstanding common stock. The disclosure was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., on November 8, 2024.
On September 30, 2024, BlackRock, Inc. filed an amended Schedule 13G/A with the SEC, indicating a significant ownership stake in Medical Properties Trust Inc. The filing revealed that BlackRock now beneficially owns 89,509,007 shares of Medical Properties Trust, representing 14.9% of the company's common stock. This position reflects BlackRock's sole voting power over 86,853,098 shares and sole dispositive power over the entire 89,509,007 shares. The filing was made in accordance with Rule 13d-1(b) under the Securities Exchange Act of 1934, which applies to parent holding companies or control persons. The address of BlackRock's principal business office is listed as 50 Hudson Yards, New York, NY 10001. Medical Properties Trust Inc., headquartered in Birmingham, AL, is the issuer of the common stock in question. The filing also notes that the iShares Core S&P Small-Cap ETF, managed by BlackRock, holds more than five percent of Medical Properties Trust's outstanding common stock. The disclosure was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., on November 8, 2024.
2024年9月30日,贝莱德公司向美国证券交易委员会提交了修订后的13G/A表,表明其在medical properties trust拥有重要的所有权。该申报显示,贝莱德现在受益拥有medical properties trust的895,090,07股股票,占公司普通股的14.9%。这一立场反映了贝莱德对8685,3098股股票拥有唯一的表决权,并对整个895,090,07股股票拥有唯一的取决权。该申报是根据1934年证券交易法第13d-1(b)条规定的,适用于母公司或控制人。贝莱德主要业务办公地点的地址列为纽约市10001号哈德逊城50号。总部位于亚拉巴马州伯明翰的medical pro...展开全部
2024年9月30日,贝莱德公司向美国证券交易委员会提交了修订后的13G/A表,表明其在medical properties trust拥有重要的所有权。该申报显示,贝莱德现在受益拥有medical properties trust的895,090,07股股票,占公司普通股的14.9%。这一立场反映了贝莱德对8685,3098股股票拥有唯一的表决权,并对整个895,090,07股股票拥有唯一的取决权。该申报是根据1934年证券交易法第13d-1(b)条规定的,适用于母公司或控制人。贝莱德主要业务办公地点的地址列为纽约市10001号哈德逊城50号。总部位于亚拉巴马州伯明翰的medical properties trust是问题股票的发行者。申报还指出,由贝莱德管理的iShares Core S&P Small-Cap ETF持有medical properties trust流通普通股的超过5%。该披露是由斯宾塞·弗莱明(Spencer Fleming)代表贝莱德公司于2024年11月8日签署的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息